These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9324807)

  • 1. [The therapy of membranous glomerulopathy].
    Ratner MIa
    Ter Arkh; 1996; 68(4):86-8. PubMed ID: 9324807
    [No Abstract]   [Full Text] [Related]  

  • 2. [The pharmacotherapy of chronic glomerulonephritis].
    Ratner MIa; Biriukova LS
    Klin Med (Mosk); 1992 Jan; 70(1):114-9. PubMed ID: 1608196
    [No Abstract]   [Full Text] [Related]  

  • 3. Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome.
    Frigui M; Hmida MB; Jallouli M; Kechaou M; Frikha F; Bahloul Z
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):320-2. PubMed ID: 20228521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide in progressive membranous glomerulopathy: pro and con.
    Agarwal R
    Ann Intern Med; 1992 Oct; 117(8):696-7. PubMed ID: 1530205
    [No Abstract]   [Full Text] [Related]  

  • 5. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Passerini P; Gagnoli L; Imbasciati E
    Adv Nephrol Necker Hosp; 1987; 16():195-218. PubMed ID: 3101424
    [No Abstract]   [Full Text] [Related]  

  • 7. Idiopathic membranous nephropathy: new therapeutic trends.
    Rostoker G
    Eur J Med; 1993 Feb; 2(2):106-16. PubMed ID: 8258013
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
    Abdel-Raheem MM; Jamil MG; Potti A; Gross GG
    Haematologica; 2000 Nov; 85(11):1224-5. PubMed ID: 11064479
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of steroid therapy on membranous nephropathy].
    Takei T; Aoki A; Eguchi A; Shimizu A; Iwasa Y; Asamiya Y; Matsuda N; Sugiura H; Itabashi M; Shirota S; Tsukada M; Yoshida T; Uchida K; Tsuchiya K; Nitta K
    Nihon Jinzo Gakkai Shi; 2008; 50(5):597-601. PubMed ID: 18767488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membranous nephropathy and its treatment.
    Cameron JS
    Nephrol Dial Transplant; 1992; 7 Suppl 1():72-9. PubMed ID: 1337186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membranous nephropathy--still a treatment dilemma.
    Cameron JS
    N Engl J Med; 1992 Aug; 327(9):638-9. PubMed ID: 1640957
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
    Riabov SI; Stavskaia VV; Sheveleva LA
    Ter Arkh; 1990; 62(9):91-7. PubMed ID: 2281418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranous glomerulonephritis and the nephrotic syndrome in a patient with Landry-Guillain-Barré-Strohl syndrome.
    Nicholson GD; Prussia PR; Sirarajan S; Evelyn SV
    West Indian Med J; 1989 Mar; 38(1):51-3. PubMed ID: 2728436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Membranous kidney diseases in adults].
    Sobarzo Toro M; Vilches A
    Medicina (B Aires); 2004; 64(1):59-65. PubMed ID: 15034960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
    Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extramembranous glomerulonephritis and myelodysplastic syndrome].
    Doukkali O; Tarrass F; Medkouri G; Fatihi E; Ramdani B; Zaid D; Azzouzi S; Sqalli S
    Nephrologie; 2004; 25(2):59-61. PubMed ID: 15119222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of treatment with corticosteroids and indomethacin on proteinuria].
    Michielsen P; Lambert PP
    J Urol Nephrol (Paris); 1967; 73(4):340-55. PubMed ID: 6066085
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of the nephrotic syndrome.
    Br Med J; 1970 Jul; 3(5714):58-9. PubMed ID: 4316980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.